American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Journal
Overview
publication venue for
Erythropoietic protoporphyria in an adult with sequential liver and hematopoietic stem cell transplantation: A case report.
2017
The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection.
2008
Carbapenem-resistant Enterobacterales in solid organ transplant recipients.
2024
Generating Strategies for a National Comeback in Pancreas Transplantation: A Delphi Survey and U.S. Conference Report.
2024
Biliary complications after adult-to-adult living-donor liver transplantation: An international multicenter study of 3633 cases.
2024
Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020. .
24.
2023
The Banff 2022 Kidney Meeting Work Plan: Data-driven Refinement of the Banff Classification for Renal Allografts.
2023
BANFF 2022 PANCREAS TRANSPLANTATION MULTIDISCIPLINARY REPORT: Refinement of guidelines for TCMR, AMR, islet and non-rejection pathologies. Assessment of duodenal cuff biopsies and non-invasive diagnostic methods.
2023
Characterizing the risk of HLA-incompatible living donor kidney transplantation in older recipients.
2023
Temporal Trends in Kidney Paired Donation in the United States: 2006 - 2021 UNOS/ OPTN Database Analysis.
2023
Smoking exposure-induced bronchus-associated lymphoid tissue in donor lungs does not prevent tolerance induction after transplantation.
2023
Addition of IL-6 receptor blockade to Carfilzomib-based desensitization in a highly sensitized nonhuman primate model.
2022
Donor-derived Acute Myeloid Leukemia in solid organ transplantation.
2022
A multi-institutional study of renal outcomes and renal-related pregnancy outcomes in uterus transplant recipients.
2022
COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era.
2022
Early clinical experience with nirmatrelvir/ritonavir for treatment of COVID-19 in solid organ transplant recipients.
2022
Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation. .
22.
2021
Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus. .
21.
2021
White paper on antimicrobial stewardship in solid organ transplant recipients.
2021
Kidney recipients with allograft failure, transition of kidney care (KRAFT): A survey of contemporary practices of transplant providers. .
21.
2021
Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation. .
21.
2021
Consensus conference on heart-kidney transplantation. .
21.
2021
An early experience on the effect of solid organ transplant status on hospitalized COVID-19 patients. .
21.
2021
COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients. .
21.
2020
Defining the roles and responsibilities of the kidney transplant medical director: A necessary step for future training, mentoring, and professional development. .
21.
2020
T cell repertoire analysis suggests a prominent bystander response in human cardiac allograft vasculopathy. .
21.
2020
A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action. .
21.
2020
The 2018 Banff Working Group classification of definitive polyomavirus nephropathy: A multicenter validation study in the modern era. .
21.
2020
Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition. .
20.
2020
Lest we forget. .
20.
2020
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. .
20.
2020
Profiling non-HLA antibody responses in antibody-mediated rejection following heart transplantation. .
20.
2020
T cell exhaustion is associated with antigen abundance and promotes transplant acceptance. .
20.
2020
Epigenetically modifying the Foxp3 locus for generation of stable antigen-specific Tregs as cellular therapeutics. .
20.
2020
Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades. .
20.
2019
Delayed autologous stem cell transplantation following cardiac transplantation experience in patients with cardiac amyloidosis. .
19.
2019
Outcomes of liver transplantation for acute fatty liver disease of pregnancy. .
19.
2019
Agree on much, except it is time for change. .
19.
2019
Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: Results of a prospective, double-blind, randomized, placebo-controlled trial. .
19.
2019
Leveraging marginal structural modeling with Cox regression to assess the survival benefit of accepting vs declining kidney allograft offers. .
19.
2019
Optimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant. .
19.
2019
Ablation of interferon regulatory factor 4 in T cells induces "memory" of transplant tolerance that is irreversible by immune checkpoint blockade. .
19.
2018
Multicenter investigation of the reliability and validity of the live donor assessment tool as an enhancement to the psychosocial evaluation of living donors. .
19.
2018
Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients. .
19.
2018
Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation. .
18.
2018
Gut microbiota dysbiosis and diarrhea in kidney transplant recipients. .
19.
2018
Banff survey on antibody-mediated rejection clinical practices in kidney transplantation: Diagnostic misinterpretation has potential therapeutic implications. .
19.
2018
Kidney offer acceptance at programs undergoing a Systems Improvement Agreement. .
18.
2018
The first 9 years of kidney paired donation through the National Kidney Registry: Characteristics of donors and recipients compared with National Live Donor Transplant Registries. .
18.
2018
A liver for a kidney: Ethics of trans-organ paired exchange. .
18.
2018
Decreasing deceased donor transplant rates among children (≤6 years) under the new kidney allocation system. .
18.
2018
Aggressive infrainguinal revascularization in renal transplant patients is justifiable. .
18.
2018
Inferior long-term allograft and patient outcomes among recipients of offspring living donor kidneys. .
18.
2018
Shipping living donor kidneys and transplant recipient outcomes. .
18.
2017
Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model. .
18.
2017
Longitudinal assessment of T cell inhibitory receptors in liver transplant recipients and their association with posttransplant infections. .
18.
2017
No country for old livers? Examining and optimizing the utilization of elderly liver grafts. .
18.
2017
A novel patient-centered "intention-to-treat" metric of U.S. lung transplant center performance. .
18.
2017
Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study. .
18.
2017
Human immunology studies using organ donors: Impact of clinical variations on immune parameters in tissues and circulation. .
18.
2017
Kidney allograft offers: Predictors of turndown and the impact of late organ acceptance on allograft survival. .
18.
2017
Impact of Protease Inhibitor-Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients. .
17.
2017
The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis. .
17.
2017
Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors. .
17.
2017
Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data. .
17.
2017
The Value of Protocol Biopsies to Identify Patients With De Novo Donor-Specific Antibody at High Risk for Allograft Loss. .
17.
2017
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. .
17.
2017
Portrayal of Brain Death in Film and Television. .
17.
2016
Banff Histopathological Consensus Criteria for Preimplantation Kidney Biopsies. .
17.
2016
Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)-Infected Recipients. .
17.
2016
Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant Recipients. .
16.
2016
Graft-Infiltrating Macrophages Adopt an M2 Phenotype and Are Inhibited by Purinergic Receptor P2X7 Antagonist in Chronic Rejection. .
16.
2016
Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes. .
16.
2016
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients. .
16.
2016
Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents. .
16.
2016
One Size Does Not Fit All--Regional Variation in the Impact of the Share 35 Liver Allocation Policy. .
16.
2015
Hospital-onset Clostridium difficile infection among solid organ transplant recipients. .
15.
2015
Complications and Their Resolution in Recipients of Deceased and Living Donor Liver Transplants: Findings From the A2ALL Cohort Study. .
16.
2015
Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study. .
16.
2015
New-Onset Diabetes After Transplantation: Results From a Double-Blind Early Corticosteroid Withdrawal Trial. .
15.
2015
Hypothermic machine preservation facilitates successful transplantation of "orphan" extended criteria donor livers. .
15.
2014
MELD exceptions for portopulmonary hypertension: current policy and future implementation. .
14.
2014
A randomized, prospective, parallel group study of laparoscopic versus laparoendoscopic single site donor nephrectomy for kidney donation. .
14.
2014
Quantifying the risk of incompatible kidney transplantation: a multicenter study. .
14.
2014
Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling. .
14.
2014
Kidneys at higher risk of discard: expanding the role of dual kidney transplantation. .
14.
2014
Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation. .
14.
2014
Natural CD8+CD122+ T cells are more potent in suppression of allograft rejection than CD4+CD25+ regulatory T cells. .
14.
2013
Induction of cardiac allograft tolerance across a full MHC barrier in miniature swine by donor kidney cotransplantation. .
13.
2013
Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling. .
13.
2013
Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study. .
13.
2012
Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. .
12.
2012
Chain transplantation: initial experience of a large multicenter program. .
12.
2012
Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction. .
12.
2012
Hypothermic machine preservation reduces molecular markers of ischemia/reperfusion injury in human liver transplantation. .
12.
2012
Complications of living donor hepatic lobectomy--a comprehensive report. .
12.
2012
Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates. .
12.
2011
The PROMISE study: a phase 2b multicenter study of voclosporin (ISA247) versus tacrolimus in de novo kidney transplantation. .
11.
2011
Nanoparticle delivery of mycophenolic acid upregulates PD-L1 on dendritic cells to prolong murine allograft survival. .
11.
2011
Complement inhibition enables renal allograft accommodation and long-term engraftment in presensitized nonhuman primates. .
11.
2011
Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema. .
11.
2011
Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. .
10.
2010
25-OH-vitamin D deficiency and cellular alloimmunity as measured by panel of reactive T cell testing in dialysis patients. .
10.
2010
Regulatory T cells are critical to tolerance induction in presensitized mouse transplant recipients through targeting memory T cells. .
10.
2010
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. .
10.
2010
Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. .
10.
2010
What defines a transplant surgeon? A needs assessment for curricular development in transplant surgery fellowship training. .
10.
2010
Hypothermic machine preservation in human liver transplantation: the first clinical series. .
10.
2009
Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations. .
9.
2009
Asynchronous, out-of-sequence, transcontinental chain kidney transplantation: a novel concept. .
9.
2009
The impact of hepatitis C and biliary complications on patient and graft survival following liver transplantation. .
9.
2009
Factors associated with failure to list HIV-positive kidney transplant candidates. .
9.
2009
Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. .
9.
2008
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. .
8.
2008
Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. .
8.
2008
Resource utilization of living donor versus deceased donor liver transplantation is similar at an experienced transplant center. .
9.
2008
Striking dichotomy of PD-L1 and PD-L2 pathways in regulating alloreactive CD4(+) and CD8(+) T cells in vivo. .
7.
2007
Expanding kidney paired donation through participation by compatible pairs. .
7.
2007
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. .
7.
2007
The effect of desensitization protocols on human splenic B-cell populations in vivo. .
7.
2007
Prevalence and risk factors for diabetes mellitus in moderate term survivors of liver transplantation. .
6.
2006
Select utilization of obese donors in living donor liver transplantation: implications for the donor pool. .
5.
2005
Predictors of candidate maturation among potential living donors. .
5.
2005
The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. .
5.
2005
Calcium oxalate deposition in renal allografts: morphologic spectrum and clinical implications. .
4.
2004
Impact of adult living donor liver transplantation on waiting time survival in candidates listed for liver transplantation. .
4.
2004
Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related. .
3.
2003
Association of humoral immunity and bronchiolitis obliterans syndrome. .
3.
2003
Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis. .
3.
2003
Use of C4d as a diagnostic adjunct in lung allograft biopsies. .
3.
2003
Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation. .
3.
2003
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. .
3.
2003
Histological grading of chronic pancreas allograft rejection/graft sclerosis. .
3.
2003
Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C. .
3.
2003
The remission of post-transplant nephrotic syndrome clinicopathologic characterization. .
2.
2002
Analysis of donor risk in living-donor hepatectomy: the impact of resection type on clinical outcome. .
2.
2002
CD2 is a dominant target for allogeneic responses. .
2.
2002
Combination of electroporation and DNA/dendrimer complexes enhances gene transfer into murine cardiac transplants. .
1.
2001
A cost-effectiveness analysis of biliary anastomosis with or without T-tube after orthotopic liver transplantation. .
1.
2001
United States donation after circulatory death liver transplantation is driven by a few high-utilization transplant centers. .
20.
2019
Re: The Pursuit of Happiness. The thin line between rights and duties. .
18.
2018
Waning humoral immune response to the BNT162b2 vaccine in heart transplant recipients over 6 months.
2022
Nirmatrelvir/ritonavir use: Managing clinically significant drug-drug interactions with transplant immunosuppressants.
2022
Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results.
2019
Identifying the best donor for the best recipient: Parents may still be better served by nonoffspring donors.
2018
Kidney transplant outcomes: Position in the match-run does not seem to matter beyond other donor risk factors.
2018
Response to: Regarding "HIV protease inhibitors and mortality following kidney transplantation".
2018
BK virus genotype variance and discordant BK viremia PCR assay results.
2013
Addressing sex-based disparities in solid organ transplantation in the United States - a conference report.
2023
Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States.
2017
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.
2010
Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation.
2005
Pure laparoscopic donor hepatectomy: A nearly finished product.
2023
Can you hear me now? Patient preferences for evaluating kidney transplant centers. .
18.
2018
Where have all the (HCV-positive) kidneys gone? .
18.
2018
If hepatitis C therapy is so great, why isn't everyone doing it? .
18.
2018
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016. .
17.
2017
Universal Hepatitis C Eradication Prior to Liver Transplantation: We Can Do It, but Should We? .
15.
2015
Right homonymous hemianopsia and seizures in a liver transplant recipient. .
14.
2014
The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution. .
5.
2005
The failing kidney allograft: A review and recommendations for the care and management of a complex group of patients.
2021
Death-defining immune responses after apoptosis.
2014
Kidney and pancreas transplantation.
2004
Liver and intestine transplantation.
2004
Management of Cardiac Diseases in Liver Transplant Recipients: Comprehensive Review and Multidisciplinary Practice-Based Recommendations.
2022
Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement.
2020
Urologic malignancies in kidney transplantation.
2017
The immunoproteasome: An old player with a novel and emerging role in alloimmunity.
2017
Consensus Conference on North American Training in Hepatopancreaticobiliary Surgery: A Review of the Conference and Presentation of Consensus Statements.
2016
Blood Vessels in Allotransplantation.
2015
Thoracic transplantation.
2003
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)
